Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Intronic variant in IQGAP3 associated with hereditary neuropathy with proximal lower dominancy, urinary disturbance, and paroxysmal dry cough

Abstract

In 2008, we reported a clinically and genetically new type of autosomal dominant disorder of motor and sensory neuropathy with proximal dominancy in the lower extremities, urinary disturbance, and paroxysmal dry cough. To identify the nucleotide variant causative of this disease, we reanalyzed the linkage of the original Japanese pedigree including seven newly ascertained subjects with updated information. We assigned the locus of the disease to 1p13.3-q23 (maximum logarithm-of-odds score = 2.71). Exome sequencing for five patients and one healthy relative from the pedigree revealed 2526 patient-specific single-nucleotide variants (SNVs). By rigorous filtering processes using public databases, our linkage results, and functional prediction, followed by Sanger sequencing of the pedigree and 520 healthy Japanese individuals, we identified an intronic SNV in IQGAP3, a gene known to be associated with neurite outgrowth. Upon pathological examination of the sural nerve, moderate, chronic, mainly axonal neuropathy was observed. By histochemical analyses, we observed a patient-specific increase of IQGAP3 expression in the sural nerve. We concluded that the variant of IQGAP3 is associated with the disease in our pedigree.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The IQGAP3 variant and the FLG variant data have been deposited to and openly available from ClinVar (Submission IDs: SUB6424734, IQGAP3; https://www.ncbi.nlm.nih.gov/clinvar/variation/694497/, FLG; https://www.ncbi.nlm.nih.gov/clinvar/variation/694498/). The data sets of this study are available from the corresponding author on reasonable request.

References

  1. Jerath NU, Shy ME. Hereditary motor and sensory neuropathies: understanding molecular pathogenesis could lead to future treatment strategies. Biochim Biophys Acta. 2015;1852:667–78.

    Article  CAS  Google Scholar 

  2. Ishiura H, Sako W, Yoshida M, Kawarai T, Tanabe O, Goto J, et al. The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. Am J Hum Genet. 2012;91:320–9.

    Article  CAS  Google Scholar 

  3. Tsai PC, Huang YH, Guo YC, Wu HT, Lin KP, Tsai YS, et al. A novel TFG mutation causes Charcot–Marie–Tooth disease type 2 and impairs TFG function. Neurology. 2014;83:903–12.

    Article  CAS  Google Scholar 

  4. Miura S, Shibata H, Kida H, Noda K, Tomiyasu K, Yamamoto K, et al. Hereditary motor and sensory neuropathy with proximal dominancy in the lower extremities, urinary disturbance, and paroxysmal dry cough. J Neurol Sci. 2008;273:88–92.

    Article  Google Scholar 

  5. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676–82.

    Article  CAS  Google Scholar 

  6. Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinform. 2017;18:529.

    Article  Google Scholar 

  7. Dyck PJ, Dyck PJB, Engelstad J. Pathological alterations of nerves. In: Dyck PJ, Thomas PK editors. Peripheral neuropathy. Philadelphia: Elsevier Saunders; 2005, p. 733–829.

  8. Wang S, Watanabe T, Noritake J, Fukata M, Yoshimsura T, Itoh N, et al. IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth. J Cell Sci. 2007;120:567–77.

    Article  CAS  Google Scholar 

  9. Nojima H, Adachi M, Matsui T, Okawa K, Tsukita S, Tsukita S. IQGAP3 regulates cell proliferation through the Ras/ERK signaling cascade. Nat Cell Biol. 2008;10:971–8.

    Article  CAS  Google Scholar 

  10. Fang X, Zhang B, Thisse B, Bloom GS, Thisse C. IQGAP3 is essential for cell proliferation and motility during zebrafish embryonic development. Cytoskeleton. 2015;72:422–33.

    Article  CAS  Google Scholar 

  11. Yang Y, Zhao W, Xu QW, Wang XS, Zhang Y, Zhang J. IQGAP3 promotes EGFR-ERK signaling and the growth and metastasis of lung cancer cells. PLoS One. 2014;9:e97578.

    Article  Google Scholar 

  12. Qian EN, Han SY, Ding SZ, Lv X. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma. Cancer Cell Int. 2016;26:55.

    Article  Google Scholar 

  13. Xu W, Xu B, Yao Y, Yu X, Cao H, Zhang J, et al. Overexpression and biological function of IQGAP3 in human pancreatic cancer. Am J Transl Res. 2016;8:5421–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Hu G, Xu Y, Chen W, Wang J, Zhao C, Wang M. RNA interference of IQ motif containing GTPase-activating protein 3 (IQGAP3) inhibits cell proliferation and invasion in breast carcinoma cells. Oncol Res. 2016;24:455–61.

    Article  Google Scholar 

  15. Shi Y, Qin N, Zhou Q, Chen Y, Huang S, Chen B, et al. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. J Transl Med. 2017;15:176.

    Article  Google Scholar 

  16. Kumar D, Hassan MK, Pattnaik N, Mohapatra N, Dixit M. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers. PLoS One. 2017;12:e0186977.

    Article  Google Scholar 

  17. Oue N, Yamamoto Y, Oshima T, Asai R, Ishikawa A, Uraoka N, et al. Overexpression of the transmembrane protein IQGAP3 is associated with poor survival of patients with gastric cancer. Pathobiology. 2018;85:192–200.

    Article  CAS  Google Scholar 

  18. Kim WT, Kim YH, Jeong P, Seo SP, Kang HW, Kim YJ, et al. Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer. Oncotarget. 2018;9:14354–65.

    Article  Google Scholar 

Download references

Acknowledgements

We thank patients and their family members for participation in the study. The authors would like to thank Enago (www.enago.jp) for the English language review.

Funding

This work was supported by the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University, and by JSPS KAKENHI (Grant number: 26460411 to S Miura).

Author information

Authors and Affiliations

Authors

Contributions

S Miura and H Shibata contributed to the study concept and design and analysis. S Miura, KK, TS, EM, KN, RF, S Mori, FU, TI, KY contributed to acquisition of data. S Mori, TI, H Saitsu contributed to the interpretation of the data. S Miura and H Shibata are responsible for the overall content.

Corresponding author

Correspondence to Hiroki Shibata.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miura, S., Kosaka, K., Shimojo, T. et al. Intronic variant in IQGAP3 associated with hereditary neuropathy with proximal lower dominancy, urinary disturbance, and paroxysmal dry cough. J Hum Genet 65, 717–725 (2020). https://doi.org/10.1038/s10038-020-0761-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-020-0761-7

Search

Quick links